This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Kelly Solar - Teaching Note
Lipson, Marc L.; Bodily, Samuel E.; Lichtendahl, Kenneth C. Jr.Teaching Note DARDEN-F-1614TN-EFinanceTeaching note for product F-1614Starting at €0.00
-
Kelly Solar
Bodily, Samuel E.; Lipson, Marc L.; Lichtendahl, Kenneth C. Jr.Case DARDEN-F-1614-EFinanceA small start-up company must make additional investments to maximize its firm value. But the company owner will not make this investment unless she can renegotiate outstanding debt claims. Solving this "debt overhang" problem through negotiation is the focus of the case. In this context, students are exposed to a variety of issues: the nature of financial claims, bargaining and negotiation fundamentals, and agency costs of debt.Starting at €8.20
-
Investcorp and the Moneybookers Bid
Rhodes-Kropf, Matthew; Knoop, Carin-Isabel; Lietz, Nori GerardoCase HBS-811013-EEntrepreneurshipIn January 2007, Hazem Ben-Gacem, managing director and co-head of Investcorp Technology Partners (ITP), needs to decide what to bid at an auction for Moneybookers Limited, one of the top three e-payment solution providers in Europe. However, approximately 70% of Moneybookers revenues were related to transactions from online gaming sites (down from 100% in 2002). Although the thesis was that e-commerce transactions would soon make up a much large...Starting at €8.20
-
Panera Bread Company (Spanish version)
Lipson, Marc L.Case DARDEN-F-1827FinanceTraducción al español de la versión del 3 de septiembre de 2009 del caso UVA-F-1575. Al finalizar el año 2007, Panera Bread Company se enfrentó un nuevo desafío. Hasta la fecha, se había basado en ganancias retenidas e infusiones menores de capital para financiar sus operaciones. Pero una disminución de los márgenes limitaría el financiamiento futuro de fondos generados internamente. Para complicar las cosas el precio de sus acciones estaba en mí...Starting at €8.20
-
Grove Street Advisors: September 2009
Rhodes-Kropf, Matthew; Leamon, AnnCase HBS-810064-EFinanceThe investment committee of Grove Street Advisors, a pioneer in the provision of customized private equity funds-of-funds for pension fund clients, must decide how to respond to the market opportunities and challenges presented by the turmoil of 2008 and 2009. How can they shift their strategy to fill new market niches, or should they stay with their successful approach thus far, even though the market is getting crowded? The case also presents b...Starting at €8.20
-
Iris Running Crane: December 2009
Rhodes-Kropf, Matthew; Lerner, Josh; Leamon, AnnCase HBS-810073-EEntrepreneurshipIris Running Crane, an MBA candidate, must choose among three different job offers in private equity. One is with a top-tier megafund buyout operation; the second with a geographically focused mid-market fund; and the third with a one-time top-tier fund that is trying to reposition itself as a turnaround expert, starting with its own portfolio. Iris must consider the advantages and drawbacks of each position, and how each will help her achieve he...Starting at €8.20
-
Grove Street Advisors: September 2009, Teaching Note
Rhodes-Kropf, Matthew; Leamon, AnnTeaching Note HBS-812094-EFinanceTeaching Note for 810-064.Starting at €0.00
-
VCPE Strategy Vignettes I, II, and 2012, Teaching Note
Rhodes-Kropf, Matthew; Burbank, NathanielTeaching Note HBS-814086-EEntrepreneurshipTeaching Note for 811043, 811054, and 812073.Starting at €0.00
-
Investcorp and the Moneybookers Bid, Teaching Note
Rhodes-Kropf, Matthew; Lobb, AnnelenaTeaching Note HBS-814093-EEntrepreneurshipTeaching Note for 811013.Starting at €0.00
-
Avid Radiopharmaceuticals: The Venture Debt Question
Rhodes-Kropf, Matthew; Leamon, AnnCase HBS-809086-EEntrepreneurshipThe CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the market. This involved expanding the firm's facilities and headcount and he planned to fund this by taking venture debt. Although clinical trial data is extremely encouraging, questions ...Starting at €8.20